mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Pradip K. Majumder(Wave Life Sciences (United States)), William R. Sellers(Broad Institute), Rachel Bikoff(Brigham and Women's Hospital), Judith Manola(Dana-Farber Cancer Institute), James Brugarolas(The University of Texas Southwestern Medical Center), Todd R. Golub(Broad Institute), Raanan Berger(Tel Aviv University), Massimo Loda(Cornell University), Louis McMahon(Tris Pharma (United States)), Heidi A. Lane(Basilea Pharmaceutica (Switzerland)), Timothy J. McDonnell(Health Service Executive), Phillip G. Febbo(Veracyte (United States)), Qi Xue(Anhui Medical University)
Nature Medicine
May 23, 2004
Cited by 956


Related Papers